Nula Therapeutics, Inc.

CIK 2121301 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Nula Therapeutics, Inc..

Recent SEC filings

FiledFormAccession number
Mar 18, 2026D0002121301-26-000001